Our experimental results prompted us to speculate whether the defective cellular HR repair capacity induced by MEnZn‐CuO NPs would enhance the sensitivity of ovarian cancer cell lines to PARP inhibitors in a synthetic lethal manner. This evidence concerns the gene PARP1 and ovarian cancer.